GlassScriptPhysician profile
Sandra L Salinas
NPI 1912662701
$1,799.17
in general payments reported to CMS, 2019-2025
11 companies · $759 in 2025
The $759 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $527 · 2023: $258 · 2024: $255 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.61 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,256.31 | 2022-2025 | Airsupra, Breztri, Lokelma |
| Novo Nordisk INC | $174.35 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $108.94 | 2022-2024 | Zepbound, Mounjaro |
| Abbvie INC. | $106.91 | 2022-2025 | |
| Exact Sciences Corporation | $35.54 | 2024-2025 | Cologuard Collection Kit |
| Nevro Corp. | $28.03 | 2024 | Senza |
| Amgen INC. | $19.56 | 2023 | Repatha, Otezla |
| Phadia US INC. | $18.85 | 2025 | Immunocap |
| Tactile Systems Technology INC | $18.12 | 2024 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $16.95 | 2024 | Capvaxive |
| Sanofi-Aventis U.S. LLC | $15.61 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Salinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.